Literature DB >> 15050115

Is the mitral valve passive flap theory overstated? An active valve is hypothesized.

T H Williams1, J Y Jew.   

Abstract

The concept that the mitral valve of the heart is a passive flap that opens and closes like a barn door has been emphasized for decades by medical and biology professors to their students. But experimental findings, which are outlined in this report, support the theory of an active valve. We hypothesize that the two leaflets of the mitral valve are actively contractile; that physical forces generated in the valve itself may stabilize and add precision to the sum of forces that regulate valve movement. This precision could be of critical significance both in the moments preceding, and during, valve opening and closing. Evidence supporting our active valve hypothesis includes the profuse innervation of motor and sensory nerves that are present in the mitral valves of all animals studied. In addition, multiple contractile cell types have been found in the mitral valve, including cardiac muscle cells, smooth muscle cells, and cardiac valvular interstitial cells. In vitro work in our laboratories using the rat mitral valve shows that not only are the valves capable of contraction and relaxation, but that the contractions and relaxations are nerve-mediated. We theorize that the rich innervation and contractile cells in the mitral valve work together to modulate fine-tuning of valve movements and tone, thereby ensuring the integrity of the valve seal. Other investigators have reported that the mitral valve demonstrates contractile activity and that denervation localized to the mitral valve affects valve competence. The evidence for an active mitral valve presented by these and other experimental studies warrant a reexamination of the validity of the passive valve concept. An accurate and full understanding of the precise movements of the valve leaflets and the mechanisms that regulate these movements is likely to provide the information needed to understand and develop treatments for many different cardiac valve problems, including mitral valve diseases such as prolapse and myxomatous degeneration. In view of the available experimental evidence, the concept that the mitral valve functions only as a passive structure is challenged by numerous anomalies. A reinterpretation of the concept of valve function that incorporates active as well as passive roles for the valve leaflets and other components of the valve apparatus would have significant implications both for the directions taken in research involving the cardiac valves and for the approaches to treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050115     DOI: 10.1016/j.mehy.2003.12.001

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  13 in total

Review 1.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

2.  Active stiffening of mitral valve leaflets in the beating heart.

Authors:  Akinobu Itoh; Gaurav Krishnamurthy; Julia C Swanson; Daniel B Ennis; Wolfgang Bothe; Ellen Kuhl; Matts Karlsson; Lauren R Davis; D Craig Miller; Neil B Ingels
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-10       Impact factor: 4.733

3.  Material properties of the ovine mitral valve anterior leaflet in vivo from inverse finite element analysis.

Authors:  Gaurav Krishnamurthy; Daniel B Ennis; Akinobu Itoh; Wolfgang Bothe; Julia C Swanson; Matts Karlsson; Ellen Kuhl; D Craig Miller; Neil B Ingels
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-11       Impact factor: 4.733

4.  Phylogeny informs ontogeny: a proposed common theme in the arterial pole of the vertebrate heart.

Authors:  Adrian C Grimes; Ana Carmen Durán; Valentín Sans-Coma; Danyal Hami; Massimo M Santoro; Miguel Torres
Journal:  Evol Dev       Date:  2010 Nov-Dec       Impact factor: 1.930

Review 5.  Cellular mechanisms in mitral valve disease.

Authors:  Kareem Salhiyyah; Magdi H Yacoub; Adrian H Chester
Journal:  J Cardiovasc Transl Res       Date:  2011-09-03       Impact factor: 4.132

6.  Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve.

Authors:  Cristina Banfi; Anna Guarino; Maura Brioschi; Stefania Ghilardi; Valeria Mastrullo; Elena Tremoli; Gianluca Polvani
Journal:  J Vis Exp       Date:  2017-06-14       Impact factor: 1.355

Review 7.  Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

Authors:  Patrick S Connell; Richard I Han; K Jane Grande-Allen
Journal:  J Vet Cardiol       Date:  2012-02-24       Impact factor: 1.701

8.  Vagal nerve stimulation reduces anterior mitral valve leaflet stiffness in the beating ovine heart.

Authors:  Julia C Swanson; Gaurav Krishnamurthy; Akinobu Itoh; John-Peder Escobar Kvitting; Wolfgang Bothe; D Craig Miller; Neil B Ingels
Journal:  J Biomech       Date:  2012-06-15       Impact factor: 2.712

9.  Complex sympathetic regulation in adolescent mitral valve prolapse.

Authors:  L Bona Olexova; Z Visnovcova; N Ferencova; A Jurko; I Tonhajzerova
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

10.  Serotonin and catecholamines in the development and progression of heart valve diseases.

Authors:  Elliott Goldberg; Juan B Grau; Jacqueline H Fortier; Elisa Salvati; Robert J Levy; Giovanni Ferrari
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.